MGRX
MANGOCEUTICALS, INC.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.20
−6.24%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.21
From 52W high−90.75%
Volume26679.00
Market cap$4.54M
P/E (TTM)—
P/S (TTM)14.4x
Div yield—
Key dataNov 4, 2026
Open
$0.21
From 52W high
−90.75%
Volume
26679.00
Market cap
$4.54M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
P/E (TTM)
—
RSI (14)
28.2
MomentumView details →
1D Return
−6.24%
YTD Return
−72.28%
SummaryUpdated Jun 1, 2026
Mangoceuticals, Inc. (NASDAQ:MGRX) is a Dallas-based telemedicine company that was incorporated in 2021 and went public in March 2023. The company operates as a subsidiary of Cohen Enterprises, Inc. and focuses on the men's wellness market through direct-to-consumer telemedicine services. Since its IPO, the company has been working to establish itself in the competitive digital health space, though it continues to face significant operational challenges as it scales its business model.
Similar companies
Latest newsMore news →
MANGOCEUTICALS, INC. issued and sold 657,000 common shares and warrants to purchase up to 657,000 shares at a combined price of $0.75 per share and warrant, for approximately $492,750 in gross proceeds.26d agoMangoceuticals closed a registered direct offering priced at a 74% premium to the recent market close.26d agoOFA Group appointed Eugene M. Johnston as Chief Financial Officer effective October 1, 2026.30d ago